GESLabs Revenue and Competitors

London, UK

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • GESLabs's estimated annual revenue is currently $6.8M per year.(i)
  • GESLabs's estimated revenue per employee is $201,000

Employee Data

  • GESLabs has 34 Employees.(i)
  • GESLabs grew their employee count by 62% last year.

GESLabs's People

NameTitleEmail/Phone
1
Quality Assurance ManagerReveal Email/Phone
2
Factory ManagerReveal Email/Phone
3
QC Laboratory TechnicianReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$58.9M2936%N/AN/A
#2
$21.1M1055%N/AN/A
#3
$113.4M5641%N/AN/A
#4
$20.9M104-5%N/AN/A
#5
$37M1849%N/AN/A
#6
$45.4M226-24%N/AN/A
#7
$16.1MN/AN/AN/A
#8
$69.7M3470%N/AN/A
#9
$8M403%N/AN/A
#10
$25.5M12728%N/AN/A
Add Company

What Is GESLabs?

GES is a specialist manufacturer of therapeutic cannabis products derived from medical-grade medical cannabis flowers designed for pharmaceutical applications. Our facility focuses on the extraction and purification of primary bulk cannabinoids, D9-THC, and CBD selected from GES network of high-quality cultivators. Though our extensive research and development programs we have developed proprietary chemo-type specific formulations of API designed to match the therapeutic aspects of medical cannabis. We offer a source-to-shelf private-label solution for cannabinoid inhalation cartridges and pharmacy syringe compound kits. See the website for more details. We manufacture all our products with pharmaceutical Good Manufacturing Practice (GMP) and have been produced with modernized pharmaceutical manufacturing technologies to ensure consistency and standardization. \n\nWe believe in harnessing nature's naturally readily abundant active therapies transformed with today’s scientific discoveries.

keywords:N/A

N/A

Total Funding

34

Number of Employees

$6.8M

Revenue (est)

62%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.4M34-3%$26M
#2
$3.9M34-46%N/A
#3
$6.6M34-17%N/A
#4
$3.3M346%N/A
#5
$6.4M340%N/A